Delhi Covid-19 update: 2nd round of sero survey begins, extended till Aug 7

A fresh sero-prevalence survey in the national capital began for a comprehensive assessment of the COVID-19 situation, but due to the Eid holiday not many samples could be collected

Coronavirus, testing
Press Trust of India New Delhi
2 min read Last Updated : Aug 02 2020 | 12:26 AM IST

A fresh sero-prevalence survey in the national capital began on Saturday for a comprehensive assessment of the COVID-19 situation, but due to the Eid holiday not many samples could be collected, officials said.

Hence, it has been decided to extend the survey till August 7, a senior official said.

Originally, the survey was supposed to be a five-day exercise from August 1-5.

It began with samples being collected from four districts, including North Delhi and Northwest Delhi, on Saturday, and will span all districts and cover various demographic segments.

A senior government official said not many samples could be collected on Saturday since it was a festival day. So, the survey has been extended by two days till August 7.

Delhi Health Minister Satyendar Jain told reporters the previous survey had indicated that about 24 per cent of the people whose samples were taken had shown presence of antibodies, meaning they had got infected and recovered.

A fresh survey is bring undertaken to find out the situation in the city since the previous sampling, so that better decisions can be made to tackle COVID-19, he said.

Earlier in the day, a senior government official said 15,000 samples would be collected as part of this exercise spanning different areas and age groups.

Representative samples will be taken from all the 11 districts of Delhi.

A sero-prevalence survey involves testing the blood serum of individuals to check for the prevalence of antibodies against infection.

The last such survey was conducted by the Delhi government in association with the National Centre for Disease Control (NCDC) from June 27 to July 10.

The second round would follow the same protocol as that of the last survey, officials said.

All chief district medical officers (CDMO) have been tasked with carrying out the survey in their districts. Random people will be tested for antibodies.

The last survey had tested 21,387 samples. Prior to that, a similar exercise was carried out in April in containment zones only.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineDelhihealthcareHealth crisis

First Published: Aug 02 2020 | 12:14 AM IST

Next Story